Fasenra for EGPA

Dr. Jessica Most, Pulmonologist and Medical Director for Eosinophilic Disorders at AstaZeneca talks about the unique mechanism of action for Fasenra (benralizumab) in the treatment of EGPA. She also covers dosing, who is eligible and how to talk with your doctors about new treatments!